Pro Medicus 

$144.00
158
+$11.86+8.98%Thursday 21:00

Statistics

Day High
118.64
Day Low
118.64
52W High
180
52W Low
74.52
Volume
13
Avg. Volume
176
Mkt Cap
15.04B
P/E Ratio
87.15
Dividend Yield
0.33%
Dividend
0.47

Upcoming

Dividends

0.33%Dividend Yield
Sep 2026
$0.26
Mar 2026
$0.23
Sep 2025
$0.20
Mar 2025
$0.16
Sep 2024
$0.15
10Y Growth
36.83%
5Y Growth
35.69%
3Y Growth
32%
1Y Growth
25.45%

Earnings

Feb 16Expected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
Next
0.34
0.74
1.13
1.53
Expected EPS
0.8520728833083495
Actual EPS
N/A

Financials

100.78%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
177.91MRevenue
179.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PMCUF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Show More
CEO
Sam Aaron Hupert
Employees
153
Country
Australia
ISIN
AU000000PME8
WKN
000591723

Listings

0 Comments

Share your thoughts

FAQs

What is Pro Medicus stock price today?▼
The current price of PMCUF is $144.00 USD — it has increased by +8.98% in the past 24 hours. Watch Pro Medicus stock price performance more closely on the chart.
What is Pro Medicus stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Pro Medicus stocks are traded under the ticker PMCUF.
Is Pro Medicus stock price growing?▼
PMCUF stock has risen by +21.38% compared to the previous week, the month change is a +37.03% rise, over the last year Pro Medicus has showed a -23.39% decrease.
What is Pro Medicus market cap?▼
Today Pro Medicus has the market capitalization of 15.04B
When is the next Pro Medicus earnings date?▼
Pro Medicus is going to release the next earnings report on February 16, 2027.
What were Pro Medicus earnings last quarter?▼
PMCUF earnings for the last quarter are 0.51 USD per share, whereas the estimation was 0.48 USD resulting in a +5.96% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pro Medicus revenue for the last year?▼
Pro Medicus revenue for the last year amounts to 177.91M USD.
What is Pro Medicus net income for the last year?▼
PMCUF net income for the last year is 179.3M USD.
Does Pro Medicus pay dividends?▼
Yes, PMCUF dividends are paid semi-annual. The last dividend per share was 0.26 . As of today, Dividend Yield (FWD)% is 0.33%.
How many employees does Pro Medicus have?▼
As of November 8, 2026, the company has 153 employees.
In which sector is Pro Medicus located?▼
Pro Medicus operates in the Health & Wellness sector.
When did Pro Medicus complete a stock split?▼
Pro Medicus has not had any recent stock splits.
Where is Pro Medicus headquartered?▼
Pro Medicus is headquartered in Richmond, Australia.